Clinical Trials Browser

Completed × Ovarian Neoplasms × ganitumab × Clear all

NCT00719212 2016-01-11

Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer

Phase 2 Completed

61 enrolled 22 charts

Ovarian Neoplasms